J Škrk

667 total citations
33 papers, 566 citations indexed

About

J Škrk is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, J Škrk has authored 33 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cancer Research, 12 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in J Škrk's work include Protease and Inhibitor Mechanisms (15 papers), Peptidase Inhibition and Analysis (6 papers) and Bone health and treatments (4 papers). J Škrk is often cited by papers focused on Protease and Inhibitor Mechanisms (15 papers), Peptidase Inhibition and Analysis (6 papers) and Bone health and treatments (4 papers). J Škrk collaborates with scholars based in Slovenia, Croatia and Italy. J Škrk's co-authors include Ivan Vrhovec, Marjan Budihna, Lojze Šmid, Branka Svetic, Primož Strojan, Janko Kos, Vito Türk, Marta Krašovec, Maja Osmak and Brigita Lenar≷cic̆ and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, European Journal of Cancer and Cancer Letters.

In The Last Decade

J Škrk

32 papers receiving 551 citations

Peers

J Škrk

ONCOL

Ivan Vrhovec Slovenia

Petra Kristel Netherlands

R Silvestrini Italy

Tserenchunt Gansukh Germany

Jia‐Quan Qu China

Chikashi Kihara Japan

Chung-Ta Lee Taiwan

Julio Vázquez Spain

Matthew Winans United States

M A Beckett United States

Ivan Vrhovec Slovenia

J Škrk

523 ×1.7

330 ×1.5

302 ×1.6

ONCOL

88 ×1.1

118 ×1.6

Citations per year, relative to J Škrk J Škrk (= 1×) peers Ivan Vrhovec

Countries citing papers authored by J Škrk

Since Specialization

Citations

This map shows the geographic impact of J Škrk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Škrk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Škrk more than expected).

Fields of papers citing papers by J Škrk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Škrk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Škrk. The network helps show where J Škrk may publish in the future.

Co-authorship network of co-authors of J Škrk

This figure shows the co-authorship network connecting the top 25 collaborators of J Škrk. A scholar is included among the top collaborators of J Škrk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Škrk. J Škrk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Strojan, Primož, Marjan Budihna, Lojze Šmid, et al.. (2001). Cathepsin B and L and stefin A and B levels as serum tumor markers in squamous cell carcinoma of the head and neck.. PubMed. 48(1). 66–71. 17 indexed citations

Čemažar, Maja, et al.. (2000). Changed delivery of boron to tumours using electroporation for boron neutron capture therapy with BSH.. British Journal of Radiology. 73(866). 195–200. 7 indexed citations

Kopitar‐Jerala, Nataša, Marco Bestagno, Xiaohui Fan, et al.. (2000). Molecular cloning and chimerisation of CDI 315B monoclonal antibody. Pflügers Archiv - European Journal of Physiology. 439(S1). r079–r080. 3 indexed citations

Osmak, Maja, Ivan Vrhovec, & J Škrk. (1999). Cisplatin Resistant Glioblastoma Cells may have Increased Concentration of Urokinase Plasminogen Activator and Plasminogen Activator Inhibitor Type 1. Journal of Neuro-Oncology. 42(2). 95–102. 14 indexed citations

Strojan, Primož, Marjan Budihna, Lojze Šmid, Ivan Vrhovec, & J Škrk. (1998). Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients. European Journal of Cancer. 34(8). 1193–1197. 37 indexed citations

Strojan, Primož, Marjan Budihna, Lojze Šmid, Ivan Vrhovec, & J Škrk. (1998). Cathepsin D in tissue and serum of patients with squamous cell carcinoma of the head and neck. Cancer Letters. 130(1-2). 49–56. 21 indexed citations

Čufer, Tanja, et al.. (1998). Effect of the multidrug resistance modulator valspodar on serum cortisol levels in rabbits. Cancer Chemotherapy and Pharmacology. 41(6). 517–521. 10 indexed citations

Fajgelj, A., et al.. (1997). Chromosome aberrations induced in human lymphocytes by U-235 fission neutrons. Strahlentherapie und Onkologie. 173(2). 91–97. 3 indexed citations

Šmid, Lojze, Primož Strojan, Marjan Budihna, et al.. (1997). Prognostic value of cathepsins B, D and stefins A and B in laryngeal carcinoma. European Archives of Oto-Rhino-Laryngology. 254(S1). S150–S153. 19 indexed citations

10.

Budihna, Marjan, Primož Strojan, Lojze Šmid, et al.. (1996). Prognostic Value of Cathepsins B, H, L, D and Their Endogenous Inhibitors. Stefins A and B in Head and Neck Carcinoma. Biological Chemistry Hoppe-Seyler. 377(6). 385–390. 69 indexed citations

11.

Čufer, Tanja, Ivan Vrhovec, J Škrk, et al.. (1995). Cyclosporine A increases serum cortisol levels in rabbits. Anti-Cancer Drugs. 6(4). 615–615. 3 indexed citations

12.

Krašovec, Marta, Branka Svetic, Brigita Lenar≷cic̆, et al.. (1995). Lysosomal Proteases Cathepsins D, B, H, L and Their Inhibitors Stefins A and B in Head and Neck Cancer. Biological Chemistry Hoppe-Seyler. 376(7). 401–406. 86 indexed citations

13.

Budihna, Marjan, et al.. (1995). Prognostic value of total cathepsin B in invasive ductal carcinoma of the breast. European Journal of Cancer. 31(5). 661–664. 12 indexed citations

14.

Svetic, Branka, J Škrk, Marjan Budihna, et al.. (1992). Cathepsins B, H and L in human breast carcinoma.. PubMed. 30(2). 69–74. 53 indexed citations

15.

Svetic, Branka, et al.. (1992). Determination of cathepsins B, H, L and kininogen in breast cancer patients.. PubMed. 38 ( Pt 2). 350–7. 7 indexed citations

16.

Osmak, Maja, et al.. (1989). The influence of cathepsin B and leupeptin on potentially lethal damage repair in mammalian cells. International Journal of Radiation Oncology*Biology*Physics. 16(3). 707–714. 3 indexed citations

17.

Korbelik, Mladen, et al.. (1988). Modification of Potentially Lethal Damage Repair by Some Intrinsic Intra- and Extracellular Agents: I. Proteinases and Proteinase Inhibitors. International Journal of Radiation Biology. 54(3). 461–474. 3 indexed citations

18.

Zorc‐Pleskovič, Ruda, et al.. (1982). Carcinogenesis after sublethal ionizing irradiation and regular avoidance irritation.. PubMed. 29(5). 517–25. 2 indexed citations

19.

Budihna, Marjan, et al.. (1980). Tumor cell repopulation in the rest interval of split-course radiation treatment.. PubMed. 156(6). 402–8. 42 indexed citations

20.

Škrk, J, et al.. (1976). Proteolytic activity in liver cells from mouse, rat, Ehrlich ascites carcinoma bearing mouse and in Ehrlich ascites carcinoma cells.. PubMed. 23(5). 515–22. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact